Van Lanschot Kempen Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Van Lanschot Kempen Investment Management's AMGN Position: Q4 2024 in Review
Van Lanschot Kempen Investment Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 60,501 shares — an estimated $19.5M sold.
Van Lanschot Kempen Investment Management first reported a position in AMGN in Q1 2019 and held it in 15 quarters. The position peaked at $21.5M in Q4 2023. 2,860 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Van Lanschot Kempen Investment Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Van Lanschot Kempen Investment Management sold 60,501 Amgen shares in Q4 2024, an estimated $19.5M.
- Van Lanschot Kempen Investment Management first reported a position in Amgen in Q1 2019 and held it in 15 quarters.
- Van Lanschot Kempen Investment Management's Amgen position peaked at $21.5M in Q4 2023.
- 2,860 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Van Lanschot Kempen Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.